Table 1 . Presence of different clinical and laboratory findings in patients with dermatomyositis .

	Present n(%)	Absence n(%)
Pyrexia	8(29.7%)	19(70.3%)
Weight loss	15(55.5%)	12(45.5%)
Fatigue	20(74.1%)	7(25.9%)
Cutaneous ulceration	12(45.5%)	15(55.5%)
Erythroderma	12(45.5%)	15(55.5%)
Panniculitis	1(3.7%)	26(96.3%)
Erythematous rashes: withsecondary changes* withoutsecondary changes	17(62.9%) 16(59.3%)	10(37.1%) 11(40.7%)
Heliotrope rash	12(45.5%)	15(55.5%)
Gottron’s papules/sign	24(88.9%)	3(11.1%)
Periungual capillary changes	25(92.6%)	2(7.4%)
Alopecia Diffuse hair loss Focal, patchy with erythema	9(33.3%) 1(3.7%)	18(66.7%) 26(96.3%)
Mechanics hands	12(45.5%)	15(55.5%)
Arthritis Severe active polyarthritis Moderately active arthritis Mild arthritis	4(14.8%) 5(18.5%) 6(22.2%)	23(85.2%) 22(81.5%) 21(77.8%)
Arthralgia	15(55.5%)	12(45.5%)
Dysphagia: Moderate/severe dysphagia Mild dysphagia	7(25.9%) 7(25.9%)	20(74.1%) 20(74.1%)
Abdominal pain Severe Moderate Mild	1(3.7%) 0 0	26(96.3%) 27(100%) 27(100%)
xRespiratory muscle weakness‏ withoutILD†: Dyspnea at rest Dyspnea on exertion	0 0	27(100%) 27(100%)
Active reversible ILD Dyspnea or cough due to ILD Parenchymal abnormalities on chest x-ray or HRCT‡ and/or ground glass shadowing on HRCT Pulmonary Function Tests: ≥ 10% change in FVC§	8(29.7%) 8(29.7%) 8(29.7%)	19(70.3%) 19(70.3%) 19(70.3%)
Dysphonia: Moderate to severe Mild	1(3.7%) 2(7.4%)	26(96.3%) 25(92.6%)
Pericarditis	1(3.7%)	26(96.3%)
Myocarditis	0	27(100%)
Arrhythmia: Severe arrhythmia Other arrhythmia, except sinus tachycardia	0 0	27(100%) 27(100%)
Sinus tachycardia	7(25.9%)	20(74.1%)
Myositis: Severe muscle inflammation Moderate muscle inflammation Mild muscle inflammation	17(62.9%) 19(70.3%) 19(70.3%)	10(37.1%) 8(29.7%) 8(29.7%)
Myalgia	4(14.8%)	23(85.2%)

*e.g. accompanied by erosions, vesiculobullous change or necrosis, †ILD: interstitial lung disease, ‡HRCT: high resolution CT scan, §FVC: Functional vital capacity